ID: ALA5087237

Max Phase: Preclinical

Molecular Formula: C45H74N12O10

Molecular Weight: 943.16

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C

Standard InChI:  InChI=1S/C45H74N12O10/c1-25(2)23-33(39(61)50-28(6)38(60)56-36(26(3)4)42(64)51-27(5)37(59)54-32(44(66)67)18-13-21-49-45(47)48)55-41(63)35-19-14-22-57(35)43(65)31(17-11-12-20-46)53-40(62)34(52-29(7)58)24-30-15-9-8-10-16-30/h8-10,15-16,25-28,31-36H,11-14,17-24,46H2,1-7H3,(H,50,61)(H,51,64)(H,52,58)(H,53,62)(H,54,59)(H,55,63)(H,56,60)(H,66,67)(H4,47,48,49)/t27-,28+,31+,32+,33+,34+,35+,36+/m1/s1

Standard InChI Key:  SSKZFTPQIDXAEU-MGFKLGSVSA-N

Associated Targets(Human)

C3a anaphylatoxin chemotactic receptor 750 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

C5a anaphylatoxin chemotactic receptor 2677 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 943.16Molecular Weight (Monoisotopic): 942.5651AlogP: -1.15#Rotatable Bonds: 28
Polar Surface Area: 349.23Molecular Species: ZWITTERIONHBA: 11HBD: 12
#RO5 Violations: 3HBA (Lipinski): 22HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.85CX Basic pKa: 11.55CX LogP: -3.27CX LogD: -5.74
Aromatic Rings: 1Heavy Atoms: 67QED Weighted: 0.03Np Likeness Score: 0.02

References

1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ..  (2021)  Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.,  64  (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174]

Source